| Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017Part 1: Definition, risk factors and assessment |
62 |
| Parasutterella, in association with irritable bowel syndrome and intestinal chronic inflammation |
29 |
| Over-the-scope clip system: A review of 1517 cases over 9 years |
27 |
| Beneficial effect of butyrate-producing Lachnospiraceae on stress-induced visceral hypersensitivity in rats |
24 |
| Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma |
22 |
| Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease |
17 |
| The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017Part 2: Management and special groups |
16 |
| Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign |
16 |
| Insights into Roseburia intestinalis which alleviates experimental colitis pathology by inducing anti-inflammatory responses |
15 |
| Comparison of the microbial community structure between inflamed and non-inflamed sites in patients with ulcerative colitis |
15 |
| The role of exosomes on colorectal cancer: A review |
14 |
| C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer |
13 |
| Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients |
12 |
| Natural history of pancreatic cystic lesions: A multicenter prospective observational study for evaluating the risk of pancreatic cancer |
12 |
| Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome |
12 |
| HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease |
12 |
| Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography |
12 |
| Impact of albumin-bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time-dependent receiver operating characteristic |
12 |
| Usefulness of shear wave elastography as a quantitative diagnosis of chronic pancreatitis |
11 |
| Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment |
11 |
| Randomized trial of vonoprazan-based versus proton-pump inhibitor-based third-line triple therapy with sitafloxacin for Helicobacter pylori |
11 |
| Irritable bowel syndrome in Asia: Pathogenesis, natural history, epidemiology, and management |
11 |
| MiR-876-3p regulates cisplatin resistance and stem cell-like properties of gastric cancer cells by targeting TMED3 |
11 |
| Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL study |
11 |
| Helicobacter pylori management in ASEAN: The Bangkok consensus report |
11 |
| Mouse models of non-alcoholic steatohepatitis: A reflection on recent literature |
10 |
| Oral microbiome alterations of healthy volunteers with proton pump inhibitor |
10 |
| Effect of the gluten-free diet on cardiovascular risk factors in patients with coeliac disease: A systematic review |
10 |
| Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis? |
10 |
| Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism |
10 |
| Vonoprazan versus proton-pump inhibitors for healing gastroesophageal reflux disease: A systematic review |
10 |
| rdxA, frxA, and efflux pump in metronidazole-resistant Helicobacter pylori: Their relation to clinical outcomes |
9 |
| Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers |
9 |
| High-mobility group box 1 protein modulated proliferation and radioresistance in esophageal squamous cell carcinoma |
9 |
| Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate |
9 |
| Novel per-oral endoscopic myotomy method preserving oblique muscle using two penetrating vessels as anatomic landmarks reduces postoperative gastroesophageal reflux |
9 |
| Effects of in-hospital exercise on sarcopenia in hepatoma patients who underwent transcatheter arterial chemoembolization |
9 |
| Magnetic compression anastomosis for biliojejunostomy and pancreaticojejunostomy in Whipple's procedure: An initial clinical study |
9 |
| Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema |
9 |
| Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice |
8 |
| miR-873-5p inhibits the progression of colon cancer via repression of tumor suppressor candidate 3/AKT signaling |
8 |
| Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome |
8 |
| The complex interplay between gastrointestinal and psychiatric symptoms in irritable bowel syndrome: A longitudinal assessment |
8 |
| Type 2 diabetes mellitus: A risk factor for progression of liver fibrosis in middle-aged patients with non-alcoholic fatty liver disease |
8 |
| Prediction of carotid intima-media thickness in obese patients with low prevalence of comorbidities by serum copper bioavailability |
8 |
| Environmental contributions to gastrointestinal and liver cancer in the Asia-Pacific region |
8 |
| Diabetes of the exocrine pancreas |
8 |
| Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study |
8 |
| Integration of hepatitis B virus S gene impacts on hepatitis B surface antigen levels in patients with antiviral therapy |
8 |
| Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness |
8 |
